Europe Blood Pressure Transducers Market

Europe Blood Pressure Transducers Market Size (2023 to 2028)

The blood pressure transducers market size in Europe is predicted to be worth USD 361.1 million by 2028 and USD 280.72 million in 2023, growing at a CAGR of 5.17% from 2023 to 2028.

The growing patient population suffering from high blood pressure in Europe is one of the major factors driving the growth of the European blood pressure transducer market. High blood pressure affects a significant percentage of the EU population aged 15 years and above, as reported in a 2019 survey. Unhealthy lifestyle choices, such as smoking, poor dietary habits, and sedentary behavior, along with factors like obesity, diabetes, and daily stress contribute to the rising incidence of high blood pressure. Transducer devices play a crucial role in the healthcare sector by monitoring invasive blood pressure parameters, including arterial pressure, central venous pressure, left arterial pressure, and pulmonary artery pressure. These devices enable healthcare professionals to obtain accurate blood pressure measurements for further diagnosis. By addressing these factors, the market holds a considerable share in the industry.

The increasing geriatric population and growing awareness among the European population regarding the availability of blood pressure transducers contribute to the growth rate of the European market. As the population ages, hypertension becomes more prevalent due to physiological changes and increased medication usage. Healthcare providers recommend the use of blood pressure transducers to accurately monitor blood pressure levels during surgeries and treatment for older individuals.

The continuous advancements in blood pressure transducer devices fuel the growth rate of the European market. Researchers and manufacturers focus on developing disposable devices that provide accurate arterial and venous blood pressure measurements. They also emphasize the production of personalized and portable devices, including wearable options like watches, fitness bands, and patches. Integration of advanced technologies and sensors enhances the accuracy of blood pressure monitoring. Additionally, increasing investments in research and development, government support, and the approval of innovative blood pressure devices drive the European market growth.

The high cost of blood pressure transducer devices primarily hampers the European market growth. Factors such as insufficient usage, limited skilled professionals, lack of awareness and time-consuming product approval processes further impede market growth in Europe. Challenges related to accuracy and the measurement environment of the devices inhibits the growth rate of the European market.

This research report on the Europe blood pressure transducers market has been segmented and sub-segmented into the following categories.

By Technology:

• Digital
• Wearable
• Others

By Type:

• Disposable
• Reusable

By End-Use:

• Hospitals
• Ambulatory Surgical Centers & Clinics
• Homecare

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

The Europe region occupied the second largest share of the global market in 2022 and is anticipated to witness a healthy CAGR during the forecast period owing to the widespread adoption of blood pressure transducers in hospitals and clinics for blood pressure diagnosis. The growing efforts by healthcare organizations to raise awareness about these devices contribute to their increased adoption across various healthcare sectors and result in regional market growth. Germany held the leading share of the European market in 2022 and is expected to grow healthy during the forecast period due to the growing number of manufacturing facilities and the high prevalence of cardiovascular diseases. The UK market is estimated to account for a notable share of the European market during the forecast period. Factors such as the growing number of clinical trials, the presence of key players, the rising number of mergers and government initiatives aimed at launching innovative devices majorly boost the UK market growth.

KEY MARKET PLAYERS:

Edwards Lifesciences Corporation, Medtronic plc, Smiths Medical, Inc., GE Healthcare and ICU Medical, Inc. are some of the notable companies in the Europe blood pressure transducers market.